An expert discusses how the “lower for longer is better” principle drives current guideline updates, with the National Lipid ...

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

The prevalence of severely elevated low-density lipoprotein cholesterol (LDL-C) has declined in recent decades, but 1 in 17 US adults in a recent analysis had levels of LDL-C that would warrant ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA —LDL cholesterol can be reduced to even more beneficial levels than ever before by use of a number ...

LOS ANGELES (KABC) -- We know untreated high cholesterol could lead to heart disease or stroke and statins are usually the gold standard treatment. However, not everyone can take them. Now, Cleveland ...

An experimental gene therapy for high cholesterol is showing promise in clinical trials and inching closer to approval. The treatment, called VERVE-102, is being tested in people with familial ...

The prevalence of elevated low-density lipoprotein cholesterol (LDL-C) has declined over the past two decades, but 1 in 17 Americans still have a level of 160-189 mg/dL, and 1 in 48 have a level ≥ 190 ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

Familial hypercholesterolemia is characterized by an elevated level of low-density lipoprotein (LDL) cholesterol and an increased risk of premature atherosclerotic cardiovascular disease. Monoclonal ...

MANNHEIM, Germany—New international data paint a very dire outlook for patients with homozygous familial hypercholesterolemia (HoFH), with investigators reporting that more than half of deaths that ...